NEW YORK, June 11 -Genomics Collaborative has signed an agreement with the Boston Cure Project for Multiple Sclerosis to further develop the organization's blood, tissue, and databank study, the organizations said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.
In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.
Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.
In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.